OpGen Reports Second Quarter 2023 Financial Results and Provides Business Update
August 10, 2023 16:15 ET
|
OpGen, Inc.
Total revenue for the first half of 2023 was approximately $1.65 million, an increase of approximately 15% compared to approximately $1.44 million in the first half of 2022Signed FIND R&D...
OpGen Enters Into Distribution Agreement for Unyvero in the U.S. with Fisher Healthcare
April 18, 2023 16:30 ET
|
OpGen, Inc.
Fisher Healthcare, a part of Thermo Fisher Scientific, will become the non-exclusive national laboratory distribution partner alongside OpGen, Inc.’s direct sales in the U.S. for the Unyvero A50...
John Phillips Joins Pharmaceutics International Inc. (Pii) as Vice President of Sales
March 14, 2023 08:00 ET
|
Pharmaceutics International Inc.
Hunt Valley, MD, March 14, 2023 (GLOBE NEWSWIRE) -- Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization (CDMO) is proud to announce that John Phillips has...
Biognosys lanza una nueva versión de Spectronaut® en el Congreso Internacional de Proteómica de HUPO
December 05, 2022 08:00 ET
|
Biognosys AG
ZÚRICH, Suiza y CANCÚN, México, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Biognosys, líder en soluciones de proteómica de última generación para la investigación en ciencias biosanitarias y...
Biognosys presenta la nuova versione di Spectronaut® al Congresso Internazionale di Proteomica HUPO
December 05, 2022 08:00 ET
|
Biognosys AG
ZURIGO, Svizzera e CANCÚN, Messico, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Biognosys, leader nelle soluzioni proteomiche di nuova generazione per la ricerca sulle scienze biologiche e lo sviluppo di...
Biognosys lanceert nieuwe versie van Spectronaut® op HUPO International Proteomics Congress
December 05, 2022 08:00 ET
|
Biognosys AG
ZÜRICH, Zwitserland en CANCUN, Mexico, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Biognosys, leider in next-generation proteomics-oplossingen voor lifescienceonderzoek en geneesmiddelenontwikkeling,...
Biognosys stellt neue Version von Spectronaut® auf dem HUPO International Proteomics Congress vor
December 05, 2022 08:00 ET
|
Biognosys AG
ZÜRICH, Schweiz und CANCUN, Mexiko, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Biognosys, ein führender Anbieter von Proteomik-Lösungen der nächsten Generation für die biowissenschaftliche Forschung und...
Biognosys lance une nouvelle version de Spectronaut® à l'occasion du congrès international de protéomique HUPO
December 05, 2022 08:00 ET
|
Biognosys AG
ZURICH, Suisse et CANCUN, Mexique, 05 déc. 2022 (GLOBE NEWSWIRE) -- Biognosys, un leader des solutions protéomiques nouvelle génération pour la recherche en sciences de la vie et le...
Biognosys Launches New Version of Spectronaut® at HUPO International Proteomics Congress
December 05, 2022 08:00 ET
|
Biognosys AG
ZURICH, Switzerland and CANCUN, Mexico, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Biognosys, a leader in next-generation proteomics solutions for life science research and drug development, will launch...
Global Coagulation Testing Market to Reach $8.8 Billion by 2031: Allied Market Research
November 28, 2022 05:32 ET
|
Allied Market Research
Portland, OR, Nov. 28, 2022 (GLOBE NEWSWIRE) -- A new business intelligence report released by Allied Market Research, the global Coagulation Testing Market generated $3.1 billion in 2021, and is...